How to get speed and depth in your Host Cell Protein (HCP) analysis

In the rapidly expanding arena of biotherapeutic analysis and bioprocess development, the analysis of host cell proteins (HCP) is transitioning to a new phase. HCPs are contaminants in biotherapeutic drug preparations, often at low ppm concentration levels, and must be monitored due to stability, efficacy and immunogenicity concerns. Often, these protein impurities will be considered Critical Quality Attributes (CQA) and can contribute to an overall risk assessment for the product.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Creating a sustainable and resilient pharma supply from raw materials to the patient

The pharma industry is 55 per cent more emission-intensive than the automotive industry, according to the report titled, Carbon footprint of the global pharmaceutical industry and relative impact of its major players. At the same time regulators and society demand safe, affordable and accessible healthcare globally.
Watch Now

Why metrics drive collaboration that’s key to healthcare IT strategy

With financial resiliency efforts, budget constraints, and staffing shortages likely to continue, 2023 could be the year when the operational efficiencies that result from partial IT outsourcing is one of your best options for staying on track with the technology innovations your healthcare organization needs.
Watch Now

Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials

Honeycomb Worldwide Inc

Learn how top pharma and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. Join this webinar to gain insights into Taking an agile approach to database buildReducing user acceptance testing (UAT) timelines with a risk-based approach. Driving innovation at your organization. This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times.
Watch Now

Improving Sterilising Filtration in the Biopharmaceutical Industry

business-review-webinars

Sterile filtration has been a cornerstone of bioprocessing for over 60 years and as the industry continues its change from stainless steel to single-use, filtration has also evolved, moving from cartridge to capsule format with several membrane types to choose from. This webinar aims to provide an overview of filtration in bioprocessing addressing key considerations when developing a biopharmaceutical manufacturing process.
Watch Now

Spotlight

resources